# Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026

- Source: PR Newswire
- Published: 2026-10-24T11:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/bio-thera-announces-promising-clinical-data-for-bat8008-in-combination-with-bat1308-in-first-line-non-small-cell-lung-cancer-at-esmo-2026-302918492.html
- Canonical: https://groundlevelnews.com/story/bio-thera-announces-promising-clinical-data-for-bat8008-in-combination-b72c98/

GUANGZHOU, China, Oct. 24, 2026 /PRNewswire/ -- Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced the presentation of clinical data for BAT8008, a TROP2-targeted antibody-drug conjugate...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire._